Article 49(2) of CSDR provides that a CSD shall provide a response to an access request from an issuer within three months. If the CSD asks the requesting issuer for additional information, does it automatically entail an extension of the three-month period?

What is meant by “continuous” assessment and monitoring of market and credit risk in Article 17(2) of RTS 6 which relates to investment firms’ post trade controls?

Who will assign the identifier for the APA?

a) Can systematic internalisers meet their quoting obligations under Article 18(1) of MiFIR for liquid instruments by providing executable quotes on a continuous basis?
b) Can client orders routed by an automated order router (AOR) system be considered as ‘prompting for a quote’ according to Article 18(1)(a) of MiFIR?
c) For how long should quotes provided by systematic internalisers be firm, or executable?
d) What are the obligations for systematic internalisers dealing in non-equity instruments for which there is no liquid market under Article 18(2) of MiFIR?
e) Which arrangements should systematic internalisers use when publishing firm quotes? Should these be the same arrangements as for equity instruments?
f) Should systematic internalisers disclose their identity when publishing firm quotes?

How should the “current volume weighted spread reflected in the order book” be calculated for negotiated transactions under Article 4(1)(b)(i) of MiFIR?